Canada Life’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,393
Closed -$19K 1924
2025
Q3
$19K Hold
4,393
﹤0.01% 1891
2025
Q2
$41K Hold
4,393
﹤0.01% 1841
2025
Q1
$43K Hold
4,393
﹤0.01% 1875
2024
Q4
$53K Hold
4,393
﹤0.01% 1888
2024
Q3
$48K Hold
4,393
﹤0.01% 1949
2024
Q2
$40K Hold
4,393
﹤0.01% 1985
2024
Q1
$36K Hold
4,393
﹤0.01% 2043
2023
Q4
$37K Hold
4,393
﹤0.01% 2062
2023
Q3
$75K Buy
4,393
+2,969
+208% +$58.3K ﹤0.01% 2022
2023
Q2
$33K Hold
1,424
﹤0.01% 2055
2023
Q1
$25K Buy
1,424
+382
+37% +$9.08K ﹤0.01% 2172
2022
Q4
$28K Hold
1,042
﹤0.01% 2194
2022
Q3
$18K Hold
1,042
﹤0.01% 2281
2022
Q2
$18K Hold
1,042
﹤0.01% 2284
2022
Q1
$19K Hold
1,042
﹤0.01% 2364
2021
Q4
$28K Hold
1,042
﹤0.01% 2311
2021
Q3
$31K Hold
1,042
﹤0.01% 2352
2021
Q2
$40K Sell
1,042
-671
-39% -$22.9K ﹤0.01% 2331
2021
Q1
$52K Hold
1,713
﹤0.01% 2281
2020
Q4
$65K Hold
1,713
﹤0.01% 2203
2020
Q3
$39K Hold
1,713
﹤0.01% 2242
2020
Q2
$42K Buy
+1,713
New +$30.3K ﹤0.01% 2272

Other funds holding REPL

Canada Life's REPL Position: Q4 2025 in Review

Canada Life sold out of Replimune Group (REPL) in Q4 2025, closing a stake of 4,393 shares — an estimated $19K sold.

Canada Life first reported a position in REPL in Q2 2020 and held it in 22 quarters. The position peaked at $75K in Q3 2023. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • Canada Life reported no remaining Replimune Group position as of Q4 2025 after selling out during the quarter.
  • Canada Life sold 4,393 Replimune Group shares in Q4 2025, an estimated $19K.
  • Canada Life first reported a position in Replimune Group in Q2 2020 and held it in 22 quarters.
  • Canada Life's Replimune Group position peaked at $75K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on Canada Life's 13F filing for Q4 2025, filed 13 Feb 2026.